Mega caps comeback, China to curb loan growth, and fallout from Archegos Mega caps comeback, China to curb loan growth, and fallout from Archegos Mega caps comeback, China to curb loan growth, and fallout from Archegos

Mega caps comeback, China to curb loan growth, and fallout from Archegos

Equities 5 minutes to read
Peter Garnry

Head of Equity Strategy

Summary:  Mega caps is the best performing equity theme in April and the main reason for the recent momentum in broad equity markets. We take a look of the potential reasons behind the move. We also discussing China's is move to curb lending growth to its lowest growth rate in 15 years while simultaneously launching its new digital currency. Finally, we focus on Archegos and its impact on markets with Credit Suisse announcing losses of $4.7bn from the Archegos fallout.

We are back analysing equities following a long Danish holiday period. Over the past week, the most notable trend has been that of mega cap stocks (companies with a market value above $300bn) up 1.5% yesterday and 3.8% in April beating all other equity themes we are tracking. Why this sudden repricing of mega caps? One explanation is a move towards safety as mega caps are more diversified and less volatile offering protection. It could also be an inflation hedge as these companies have a much better chance of outgrowing inflation and thus protecting the capital of investors. Finally, the much stronger than expected US economic data, the Eurocoin Growth indicator in Europe has also never been higher, could also bolster expectations of a broad economic recovery which will shine on the world’s largest companies.

Is China’s lending curb a deal breaker on inflation?

Chinese banks have just reported Q4 earnings when Chinese regulators announced today that lending growth will be curbed to 11% this year the slowest increase in more than 15 years. This news comes as China is also announced the creation of its digital currency, the first for a major economy and potentially a threat to the US global reserve banking system. While the curb on lending is potentially a negative for our inflation outlook, our view is that the curb is mainly due to adequate stimulus coming from the US over the next year which will flow to China as the country exports a lot for the US economy. This will bolster growth in China regardless of domestic lending growth. In the end the ultimate catalyst on inflation will be physical constraints of metals and energy etc. The curb on lending is also wise given China’s relentless push to expand credit while the Chinese equity market has not approved the credit quality – this can be observed by the market cap to total assets ratio (see chart). This ratio expands when credit quality improves and falls when credit quality is deteriorating.

Did markets dodge a bullet on Archegos collapse?

The fallout of Archegos Capital Management is potentially losses of $7-10bn as highly leveraged total return swaps soured when Chinese technology stocks and other bets underperformed relative to benchmark equity indices in the US. Nomura and Credit Suisse are the biggest losers from the forced liquidation that started with Morgan Stanley and Goldman Sachs, with Credit Suisse announcing today $4.7bn in losses and cutting dividends while firing several key executives. What is up and down here, and is more coming?

First, it seems the risk from Archegos is contained with only downward pressure in selected positions and no contagion risks spreading to other parts of the equity market. While total return swaps have suddenly become a new word for many, they are quite simple instruments and used a lot as they are a cost-effective way of expressing relative performance between groups of equities. The biggest fallout from Archegos is that the losses came from a family office which are not heavily regulated and many failing hedge fund owners have recently transformed into family offices to avoid regulatory oversight giving more flexibility on position sizes etc. The likely result of Archegos is that prime brokerage businesses (the investment banking division that deals with large hedge funds providing securities lending and leverage etc.) will scale down risk in general and increased their scrutiny of the risk of family offices. Credit Suisse is continuing to sell large blocks of equities today in positions related to Archegos.

Source: Saxo Group

The Saxo Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website is not intended to and does not change or expand on this. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Please read our disclaimers:
- Notification on Non-Independent Investment Research (
- Full disclaimer (

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments. Saxo does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo or its affiliates.

Saxo Capital Markets HK Limited
19th Floor
Shanghai Commercial Bank Tower
12 Queen’s Road Central
Hong Kong

Contact Saxo

Select region

Hong Kong S.A.R
Hong Kong S.A.R

Saxo Capital Markets HK Limited (“Saxo”) is a company authorised and regulated by the Securities and Futures Commission of Hong Kong. Saxo holds a Type 1 Regulated Activity (Dealing in Securities); Type 2 Regulated Activity (Dealing in Futures Contract); Type 3 Regulated Activity (Leveraged Foreign Exchange Trading); Type 4 Regulated Activity (Advising on Securities) and Type 9 Regulated Activity (Asset Management) licenses (CE No. AVD061). Registered address: 19th Floor, Shanghai Commercial Bank Tower, 12 Queen’s Road Central, Hong Kong.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products may result in your losses exceeding your initial deposits. Saxo does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo does not take into account an individual’s needs, objectives or financial situation. Please click here to view the relevant risk disclosure statements.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit

The information or the products and services referred to on this site may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and services offered on this website are not directed at, or intended for distribution to or use by, any person or entity residing in the United States and Japan. Please click here to view our full disclaimer.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc. Android is a trademark of Google Inc.